Literature DB >> 28944052

The Role of the Hepatopathologist in the Assessment of Drug-induced Liver Injury.

David E Kleiner.   

Abstract

Entities:  

Year:  2017        PMID： 28944052      PMCID： PMC5604852          DOI： 10.1002/cld.612

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  7 in total

Review 1.  The role of the human pathologist in the management of drug induced hepatic injury.

Authors:  H Popper
Journal:  Hum Pathol       Date:  1975-11       Impact factor: 3.466

2.  DRUG-INDUCED LIVER DISEASE: A PENALTY FOR PROGRESS.

Authors:  H POPPER; E RUBIN; D CARDIOL; F SCHAFFNER; F PARONETTO
Journal:  Arch Intern Med       Date:  1965-02

3.  Teaching monograph. Tissue reactions to drugs.

Authors:  N S Irey
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

Review 4.  Drug hepatotoxicity.

Authors:  Zachary D Goodman
Journal:  Clin Liver Dis       Date:  2002-05       Impact factor: 6.126

Review 5.  The pathology of drug-induced liver injury.

Authors:  David E Kleiner
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115

6.  The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury.

Authors:  E Björnsson; E Kalaitzakis; R Olsson
Journal:  Aliment Pharmacol Ther       Date:  2007-06-15       Impact factor: 8.171

7.  Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.

Authors:  David E Kleiner; Naga P Chalasani; William M Lee; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Paul H Hayashi; Timothy J Davern; Victor Navarro; Rajender Reddy; Jayant A Talwalkar; Andrew Stolz; Jiezhun Gu; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2013-12-18       Impact factor: 17.425
  7 in total
  1 in total

1.  Zhuang Gu Guan Jie Wan: Reasonable Application Can Alleviate the Liver Injury for Osteoarthritis Treatment.

Authors:  Bin Liu; Danping Fan; Wen Sun; Kang Zheng; Guoming Pang; Xiaojuan He; Cheng Xiao; Cheng Lu
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-12       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.